CoChat
Sign Up
Cited by 163

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

Minucci, Saverio, Nervi, Clara, Coco, Francesco Lo, Pelicci, Pier Giuseppe·2001·Oncogene
DOI 10.1038/sj.onc.1204336
Open this paper in CoChat — free account

Abstract

Recent discoveries have identified key molecular events in the pathogenesis of acute promyelocytic leukemia (APL), caused by chromosomal rearrangements of the transcription factor RAR (resulting in a fusion protein with the product of other cellular genes, such as PML). Oligomerization of RAR, through a self-association domain present in PML, imposes an altered interaction with transcriptional co-regulators (NCoR/SMRT). NCoR/SMRT are responsible for recruitment of histone deacetylases (HDACs), which is required for transcriptional repression of PML-RAR target genes, and for the transforming potential of the fusion protein. Oligomerization and altered recruitment of HDACs are also responsible for transformation by the fusion protein AML1-ETO, extending these mechanisms to other forms of acute myeloid leukemias (AMLs) and suggesting that HDAC is a common target for myeloid leukemias. Strikingly, AML1-ETO expression blocks retinoic acid (RA) signaling in hematopoietic cells, suggesting that interference with the RA pathway (genetically altered in APL) by HDAC recruitment may be a common theme in AMLs. Treatment of APLs with RA, and of other AMLs with RA plus HDAC inhibitors (HDACi), results in myeloid differentiation. Thus, activation of the RA signaling pathway and inhibition of HDAC activity might represent a general strategy for the differentiation treatment of myeloid leukemias.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1204336

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 42

  1. Baylin SB, Herman JG . 2000 Trends Genet. 16: 168–174 · DOI
  2. Borden KL . 1998 Biochem. Cell. Biol. 76: 351–358 · DOI
  3. Casini T, Pelicci PG . 1999 Oncogene 18: 3235–3243 · DOI
  4. Deininger MW, Goldman JM . 1998 Curr. Opin. Hematol. 5: 302–308 · DOI
  5. Dobson CL, Warren AJ, Pannell R, Forster A, Rabbitts TH . 2000 EMBO J. 19: 843–851 · DOI
  6. Ferrara F, Fazi F, Padula F, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C . 2001 Cancer Res in press
  7. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA . 1998 Mol. Cell. Biol. 18: 7185–7191 · DOI
  8. Glass CK, Rosenfeld MG . 2000 Genes Dev. 14: 121–141 · DOI · Paper page
  9. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S, Pelicci PG . 1998 Nature 391: 815–818 · DOI
  10. Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, Shiekhattar R . 2000 Genes Dev. 14: 1048–1057 · DOI · Paper page
  11. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A . 1998 Blood 91: 2634–2642 · DOI
  12. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP . 1998 Nat. Genet. 18: 126–135 · DOI
  13. Hiebert SW, Downing JR, Lenny N, Meyers S . 1996 Curr. Top. Microbiol. Immunol. 211: 253–258 · DOI
  14. Huang EY, Zhang J, Miska EA, Guenther MG, Kouzarides T, Lazar MA . 2000 Genes Dev. 14: 45–54 · DOI
  15. Kastner P, Lawrence J, Waltzinger C, Ghyselinck N, Chambon P, Chan S . 2001 Blood in press
  16. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M . 1998 EMBO J. 17: 2994–3004 · DOI
  17. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA . 1997 Science 278: 1309–1312 · DOI
  18. Lemon B, Tjian R . 2000 Genes Dev. 14: 2551–2569 · DOI
  19. Lin RJ, Evans RM . 2000 Mol. Cell 5: 821–830 · DOI
  20. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH, Evans RM . 1998 Nature 391: 811–814 · DOI
  21. Liu M, Iavarone A, Freedman LP . 1996a J. Biol. Chem. 271: 31723–31728 · DOI
  22. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP . 1996b Genes Dev. 10: 142–153 · DOI
  23. Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG . 1999 Blood 94: 12–22 · DOI
  24. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW . 1998 Mol. Cell. Biol. 18: 7176–7184 · DOI
  25. Marks PA, Richon VM, Rifkind RA . 2000 J. Natl. Cancer Inst. 92: 1210–1216 · DOI
  26. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y . 1997 Mol. Cell. Biol. 17: 2933–2943 · DOI
  27. Melnick A, Licht JD . 1999 Blood 93: 3167–3215 · DOI
  28. Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Matteucci C, Gobbi A, Bianchini A, Colombo E, Schiavoni I, Badaracco G, Hu X, Lazar MA, Landsberger N, Nervi C, Pelicci PG . 2000 Mol. Cell 5: 811–820 · DOI
  29. Minucci S, Pelicci PG . 1999 Semin. Cell. Dev. Biol. 10: 215–225 · DOI
  30. Ng HH, Bird A . 2000 Trends Biochem. Sci. 25: 121–126 · DOI
  31. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ . 1995 Science 267: 1024–1027 · DOI
  32. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG . 2000 Nature 406: 207–210 · DOI
  33. Prowse DM, Bolgan L, Molnar A, Dotto GP . 1997 J. Biol. Chem. 272: 1308–1314 · DOI
  34. Saurin AJ, Borden KL, Boddy MN, Freemont PS . 1996 Trends Biochem. Sci. 21: 208–214 · DOI
  35. Strahl BD, Allis CD . 2000 Nature 403: 41–45 · DOI · Paper page
  36. Uchida H, Downing JR, Miyazaki Y, Frank R, Zhang J, Nimer SD . 1999 Oncogene 18: 1015–1022 · DOI
  37. Warrell Jr RP, He LZ, Richon V, Calleja E, Pandolfi PP . 1998 J. Natl. Cancer Inst. 90: 1621–1625 · DOI · Paper page
  38. Westervelt P, Ley TJ . 1999 Blood 93: 2143–2148 · DOI
  39. Xu L, Glass CK, Rosenfeld MG . 1999 Curr. Opin. Genet. Dev. 9: 140–147 · DOI
  40. Zeng YX, Somasundaram K, el-Deiry WS . 1997 Nat. Genet. 15: 78–82 · DOI
  41. Zhang J, Hug B, Huang E, Chen C, Gelmetti V, Maccarana M, Minucci S, Pelicci PG, Lazar MA . 2001 Mol. Cell. Biol. 21: 156–163 · DOI
  42. Zhong S, Salomoni P, Pandolfi PP . 2000 Nat. Cell. Biol. 2: E85–E90 · DOI

Cited by

Sorted by citations

See all 163

Metadata

Authors
Minucci, S., Nervi, C., Coco, F. L., & Pelicci, P. G.
Venue
Oncogene
Publisher
Springer Science and Business Media LLC
Published
2001-05-28
Volume
20
Issue
24
Pages
3110-3115
ISSN
  • 0950-9232
  • 1476-5594
DOI
10.1038/sj.onc.1204336
Cited by
163
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review